[PDF][PDF] Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis

T Tuganbaev, U Mor, S Bashiardes, T Liwinski… - Cell, 2020 - cell.com
T Tuganbaev, U Mor, S Bashiardes, T Liwinski, SP Nobs, A Leshem, M Dori-Bachash…
Cell, 2020cell.com
Throughout a 24-h period, the small intestine (SI) is exposed to diurnally varying food-and
microbiome-derived antigenic burdens but maintains a strict immune homeostasis, which
when perturbed in genetically susceptible individuals, may lead to Crohn disease. Herein,
we demonstrate that dietary content and rhythmicity regulate the diurnally shifting SI
epithelial cell (SIEC) transcriptional landscape through modulation of the SI microbiome. We
exemplify this concept with SIEC major histocompatibility complex (MHC) class II, which is …
Summary
Throughout a 24-h period, the small intestine (SI) is exposed to diurnally varying food- and microbiome-derived antigenic burdens but maintains a strict immune homeostasis, which when perturbed in genetically susceptible individuals, may lead to Crohn disease. Herein, we demonstrate that dietary content and rhythmicity regulate the diurnally shifting SI epithelial cell (SIEC) transcriptional landscape through modulation of the SI microbiome. We exemplify this concept with SIEC major histocompatibility complex (MHC) class II, which is diurnally modulated by distinct mucosal-adherent SI commensals, while supporting downstream diurnal activity of intra-epithelial IL-10+ lymphocytes regulating the SI barrier function. Disruption of this diurnally regulated diet-microbiome-MHC class II-IL-10-epithelial barrier axis by circadian clock disarrangement, alterations in feeding time or content, or epithelial-specific MHC class II depletion leads to an extensive microbial product influx, driving Crohn-like enteritis. Collectively, we highlight nutritional features that modulate SI microbiome, immunity, and barrier function and identify dietary, epithelial, and immune checkpoints along this axis to be potentially exploitable in future Crohn disease interventions.
cell.com